Norris Medicines Ltd

Norris Medicines Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Norris Medicines Ltd

₹ 18.0 -4.45%
13 Jun - close price
norrispharma.com BSE: 524414
About

Incorporated in 1990, Norris Medicines Ltd manufacturers Injections and Medicinal formulations

Key Points

Business Overview:[1]
Company is in Health Care Industry and does contract manufacturing and Loan License Manufacturing for pharma companies.

Website BSE
  • Market Cap ₹ 18.0 Cr.
  • Current Price ₹ 18.0
  • High / Low ₹ 27.7 / 11.4
  • Stock P/E
  • Book Value ₹ -14.9
  • Dividend Yield 0.00 %
  • ROCE -10.1 %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -5.78% over past five years.
  • Promoter holding is low: 34.0%
  • Debtor days have increased from 68.4 to 88.4 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Services Services Commercial Services & Supplies Trading & Distributors

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
0.84 0.95 3.03 3.16 1.21 0.95 2.56 0.65 1.49 0.72 1.27 1.11 2.72
1.26 1.15 2.79 2.82 0.66 1.33 2.80 0.69 1.01 0.88 1.42 1.14 2.65
Operating Profit -0.42 -0.20 0.24 0.34 0.55 -0.38 -0.24 -0.04 0.48 -0.16 -0.15 -0.03 0.07
OPM % -50.00% -21.05% 7.92% 10.76% 45.45% -40.00% -9.38% -6.15% 32.21% -22.22% -11.81% -2.70% 2.57%
0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.03 0.01 0.00 0.00 0.05
Interest 0.08 0.09 0.65 0.39 0.37 0.09 0.09 0.09 0.11 0.08 0.08 0.12 0.15
Depreciation 0.66 0.15 0.15 0.15 0.18 0.14 0.14 0.14 0.14 0.13 0.13 0.13 0.14
Profit before tax -1.16 -0.44 -0.56 -0.20 0.01 -0.61 -0.47 -0.27 0.26 -0.36 -0.36 -0.28 -0.17
Tax % 93.10% 0.00% 0.00% 0.00% 5,600.00% 0.00% 0.00% 0.00% 34.62% 0.00% 0.00% 0.00% 35.29%
-2.23 -0.44 -0.56 -0.20 -0.54 -0.61 -0.48 -0.27 0.17 -0.37 -0.36 -0.28 -0.23
EPS in Rs -2.23 -0.44 -0.56 -0.20 -0.54 -0.61 -0.48 -0.27 0.17 -0.37 -0.36 -0.28 -0.23
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
20.70 18.68 18.86 20.46 13.57 16.26 7.84 12.25 9.44 8.36 5.64 5.82
21.76 16.97 18.03 20.46 15.49 16.87 10.00 14.00 9.52 7.43 5.81 6.08
Operating Profit -1.06 1.71 0.83 0.00 -1.92 -0.61 -2.16 -1.75 -0.08 0.93 -0.17 -0.26
OPM % -5.12% 9.15% 4.40% 0.00% -14.15% -3.75% -27.55% -14.29% -0.85% 11.12% -3.01% -4.47%
0.12 0.15 0.30 0.06 0.14 0.04 0.09 0.05 0.03 0.01 0.01 0.06
Interest 0.45 0.54 0.67 0.60 0.70 0.73 0.88 1.63 1.48 1.50 0.37 0.44
Depreciation 1.17 1.31 0.60 0.65 0.71 0.71 0.73 0.67 0.66 0.63 0.57 0.54
Profit before tax -2.56 0.01 -0.14 -1.19 -3.19 -2.01 -3.68 -4.00 -2.19 -1.19 -1.10 -1.18
Tax % -42.97% 10,500.00% -128.57% -35.29% -21.00% -16.42% -22.83% 24.25% 49.32% 47.06% 8.18% 5.08%
-1.45 -1.04 0.04 -0.77 -2.51 -1.68 -2.84 -4.96 -3.26 -1.75 -1.19 -1.24
EPS in Rs -1.45 -1.04 0.04 -0.77 -2.51 -1.68 -2.84 -4.96 -3.26 -1.75 -1.19 -1.24
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -11%
5 Years: -6%
3 Years: -15%
TTM: 3%
Compounded Profit Growth
10 Years: -2%
5 Years: 9%
3 Years: 17%
TTM: -6%
Stock Price CAGR
10 Years: %
5 Years: 47%
3 Years: 13%
1 Year: 59%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 9.93 9.93 9.93 9.93 9.93 9.93 9.93 9.93 9.93 9.93 9.93 9.93
Reserves -3.58 -4.63 -4.60 -5.36 -7.88 -9.55 -12.39 -17.36 -20.62 -22.37 -23.56 -24.79
7.52 8.16 7.51 7.57 7.71 11.24 17.92 15.52 21.08 21.40 21.52 21.58
7.45 4.69 5.06 9.90 10.92 8.76 5.10 11.69 3.80 4.72 6.29 7.09
Total Liabilities 21.32 18.15 17.90 22.04 20.68 20.38 20.56 19.78 14.19 13.68 14.18 13.81
8.97 8.61 8.34 9.97 9.32 8.90 8.25 7.67 7.07 6.47 5.79 5.27
CWIP 0.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
12.24 9.53 9.55 12.06 11.35 11.47 12.30 12.10 7.11 7.20 8.38 8.53
Total Assets 21.32 18.15 17.90 22.04 20.68 20.38 20.56 19.78 14.19 13.68 14.18 13.81

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1.44 -1.43 1.35 -0.96 0.80 -1.92 -2.88 1.11 -1.01 1.20 0.17 0.30
-1.75 -0.88 -0.34 -2.05 -0.08 -0.29 0.00 -0.06 -0.09 -0.02 0.05 0.58
0.02 0.10 -1.32 3.16 -0.66 2.18 2.86 -1.09 1.10 -1.18 -0.20 -0.49
Net Cash Flow -0.28 -2.21 -0.31 0.15 0.06 -0.02 -0.02 -0.04 0.00 0.00 0.02 0.40

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 91.34 73.66 53.61 84.20 66.44 67.57 128.49 53.33 42.15 48.03 68.60 88.43
Inventory Days 74.17 100.05 134.23 129.50 238.53 134.81 323.82 212.99 157.45 347.62 594.15 436.94
Days Payable 151.02 111.66 99.30 125.29 252.40 139.83 233.37 218.83 86.53 149.91 244.25 320.57
Cash Conversion Cycle 14.50 62.06 88.54 88.41 52.56 62.55 218.94 47.49 113.06 245.73 418.51 204.80
Working Capital Days 16.22 40.84 35.22 -16.06 -91.18 -32.55 -30.73 -103.69 17.40 7.86 -12.94 -50.17
ROCE % 4.02% 4.03% -4.08% -22.92% -11.97% -20.68% -20.13% -7.68% 3.20% -8.43% -10.14%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
34.04% 34.04% 34.04% 34.04% 34.01% 34.01% 34.01% 34.01% 34.01% 34.01% 34.00% 34.00%
0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07%
65.89% 65.88% 65.88% 65.88% 65.90% 65.91% 65.91% 65.91% 65.90% 65.91% 65.92% 65.93%
No. of Shareholders 25,29425,32925,38725,32625,25625,24225,31725,51725,40025,49825,65925,815

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports